Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Cold and hot tumors: from molecular mechanisms to targeted therapy
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
2 intermediate papers

Works of Anna Ejduk being referenced

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
2017

Author Peers

Author Last Decade Papers Cites
Anna Ejduk 101 11 101 85 11 193
HT Greinix 163 31 36 89 16 295
Núbia Mendonça 53 14 77 141 17 268
G. Tschurtschenthaler 108 62 86 86 10 294
Maxine Hetherington 37 28 69 45 15 271
Jean Maupas 164 32 53 82 14 273
Caroline Jacquy 89 20 71 96 12 227
Erin Coughlin 130 23 53 83 15 273
Maddalena Migliavacca 122 24 49 50 12 295
Lara Malerba 128 52 45 147 18 254
Montserrat Torrent 54 24 41 23 11 142

All Works

Loading papers...

Rankless by CCL
2026